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Akt/PKB localisation and 3′ phosphoinositide generation at sites
of epithelial cell–matrix and cell–cell interaction
Sandra J. Watton and Julian Downward
Protein kinase B (PKB or Akt) is a mitogen-regulated
protein kinase involved in the protection of cells from
apoptosis, the promotion of cell proliferation and
diverse metabolic responses [1]. Its activation is
initiated by the binding of 3′ phosphorylated
phosphoinositide lipids to its pleckstrin homology (PH)
domain, resulting in the induction of activating
phosphorylation at residues Thr308 and Ser473 by
upstream kinases such as phosphoinositide-dependent
protein kinase-1 (PDK1) [2]. Adhesion of epithelial cells
to extracellular matrix leads to protection from
apoptosis via the activation of phosphoinositide (PI) 
3-kinase and Akt/PKB through an unknown mechanism
[3,4]. Here, we use the localisation of Akt/PKB within
the cell to probe the sites of induction of PI 3-kinase
activity. In fibroblasts, immunofluorescence microscopy
showed that endogenous Akt/PKB localised to
membrane ruffles at the outer edge of the cell following
mitogen treatment as did green fluorescent protein
(GFP) fusions with full-length Akt/PKB or its PH domain
alone. In epithelial cells, the PH domain of Akt/PKB
localised to sites of cell–cell and cell–matrix contact,
distinct from focal contacts, even in the absence of
serum. As this localisation was disrupted by PI 3-kinase
inhibitory drugs and by mutations that inhibit interaction
with phosphoinositides, it is likely to represent the sites
of constitutive 3′ phosphoinositide generation that
provide a cellular survival signal. We propose that the
attachment-induced, PI-3-kinase-mediated survival
signal in epithelial cells is generated not only by
cell–matrix interaction but also by cell–cell interaction.
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Results and discussion
To determine the cellular location of activated endogenous
Akt/PKB, a polyclonal antibody was generated against a
phosphopeptide based on the sequence of the phosphoryla-
tion site at Ser473. Using this antibody, NIH3T3 cells were
examined by immunofluorescence confocal microscopy and
western blotting. Phosphorylation of Akt/PKB at Ser473
occurred at very low levels in NIH3T3 cells that had been
serum-starved overnight (Figure 1a,d). Akt/PKB was phos-
phorylated at Ser473 and found abundantly at plasma mem-
brane ruffles in cells that had been stimulated with
platelet-derived growth factor (PDGF) for 5 minutes
(Figure 1b,d). The specificity of the antibody was verified
by peptide competition experiments (Figure 1c,e). Previ-
ously, Andjelkovic et al. [5] have shown that when overex-
pressed in 293 cells, Akt/PKB translocates to the plasma
membrane following mitogen treatment. We show here for
the first time that endogenous phosphorylated Akt/PKB can
be visualised at plasma membrane ruffles following its acti-
vation by PDGF treatment of fibroblasts. 
Although it is possible that the distribution of Akt/PKB
seen in Figure 1 reflects the location of PIP3 and PI(3,4)P2,
which bind to the PH domain of Akt/PKB, the distribution
could also be influenced by sequences outside the PH
domain that might bind other molecules and by the fact
that the cells have been fixed and permeabilised for
immunofluorescence. GFP fusion proteins were therefore
generated by linking GFP, via a linker, to the amino termi-
nus of full-length, mutant and truncated forms of Akt/PKB
(see Supplementary material published with this paper on
the internet). Mutations used were R25C, which blocks
the binding of 3′ phosphoinositides to Akt/PKB, and
K179M, which ablates its kinase activity [6]. GFP was also
fused to a truncated protein termed AH, which contains
the Akt/PKB amino-terminal regulatory region (amino
acids 1–147) that spans the PH domain [7]. Correct expres-
sion and activity of the fusion proteins was verified by
transfection into COS7 cells (see Supplementary material). 
NIH3T3 cells were transiently transfected with the
GFP–Akt/PKB constructs and serum-starved for 8 hours.
Confocal images were taken before stimulation with PDGF
and at various times up to 30 minutes after stimulation.
GFP–Akt was in the cytoplasm and nucleus of serum-
starved cells but rapidly translocated to the plasma mem-
brane following PDGF treatment (Figure 2i–l), displaying
much the same pattern shown by the endogenous activated
protein in immunofluorescence experiments. GFP–Akt
disappeared most rapidly from the cytoplasm, and then
from the nucleus, gradually reappearing at both locations
by 30 minutes after PDGF treatment. GFP–AH, contain-
ing only the PH domain of Akt/PKB, also translocated to
the plasma membrane in response to PDGF (Figure 2a–c),
as did kinase-inactive GFP–AktK179M (Figure 2w), whereas
the PH domain mutants GFP–AktR25C and GFP–AHR25C
did not (Figure 2u,v). These data are consistent with previ-
ous reports on fixed cells [5] and show that in live fibrob-
lasts Akt/PKB translocates to the plasma membrane
following growth factor treatment; this requires the PH
domain but not the kinase activity of Akt/PKB. Little evi-
dence could be seen for mitogen-induced accumulation of
Akt/PKB in the nucleus, although a minor fraction of the
protein could accumulate in this manner.
In addition to this PDGF-induced response, epidermal
growth factor (EGF; Figure 2e), insulin (Figure 2f) and
0.5% serum (Figure 2g) also induced the translocation of
GFP–AH to the membrane. Addition of the PI 3-kinase
inhibitor LY294002 to cells stimulated with 0.5% serum
caused GFP–AH to move back to the cytoplasm and
nucleus within 10 minutes (Figure 2h), and pretreatment
of cells with either LY294002 or wortmannin prevented
the PDGF-induced movement of GFP–Akt to the plasma
membrane (Figure 2n,o). To investigate whether PI 
3-kinase activation is sufficient, as well as necessary, to
cause the translocation of GFP–AH and GFP–Akt,
NIH3T3 cells were transfected with these GFP constructs
together with constitutively active PI 3-kinase (p110CAAX);
expression of p110CAAX was sufficient to induce mem-
brane translocation of the fusion proteins (Figure 2p–s).
Finally, given that it has been reported that ceramide
inhibits the activation of Akt/PKB [8,9], we investigated
whether ceramide could interfere with Akt/PKB transloca-
tion. Treating the cells with 30 µM C2-ceramide for 1 hour
prior to stimulation with PDGF prevented the membrane
translocation of both GFP–AH and GFP–Akt
(Figure 2d,m), indicating that ceramide either inhibits PI
3-kinase activation or inhibits the ability of PI 3-kinase
products to interact with the PH domain of Akt/PKB.
Does the membrane localisation of Akt/PKB, particularly of
the isolated PH domain, really reflect the position of PIP3
and PI(3,4)P2 within the cell? A number of considerations
suggest that it does: firstly, PI 3-kinase inhibitory drugs
block the membrane translocation of Akt/PKB whereas
expression of activated PI 3-kinase induces membrane
translocation. Secondly, mutation of a single residue in the
PH domain essential for PIP3 and PI(3,4)P2 binding totally
eliminates membrane localisation. Thirdly, the time course
of the induction of membrane translocation is similar to that
of the accumulation of PIP3 and PI(3,4)P2 [10], although it
is more sustained; this could be due to the bound PH
domain protecting the phosphoinositides, once they have
formed, from the action of phosphatases within the cell.
The localisation of GFP–AH was examined in an epithe-
lial MDCK cell line that either transiently or stably
expressed the protein. The horizontal and vertical confocal
images in Figure 3a show that GFP–AH is present at
cell–cell (lateral) and cell–matrix (basal) contacts in
polarised MDCK cells stably expressing the fusion
protein. Most GFP–AH remained at these sites after con-
fluent MDCK cells were serum-starved overnight, indicat-
ing that these cells have high basal levels of PI 3-kinase
activity (Figure 3b; in this case transient expression of
GFP–AH was used, with only one cell in the field express-
ing the protein). The localisation of GFP–AH at the mem-
brane in epithelial cells is also dependent on PI 3-kinase
activity, because LY294002 caused GFP–AH to move
away from the membrane within 10 minutes (Figure 3c,d).
Previously, we have reported that MDCK cells have a high
basal level of PIP3 and PI(3,4)P2 in the absence of serum
that is dependent on their adhesion to matrix [3]. This ele-
vated PI 3-kinase activity is a result of integrin signalling,
although production of autocrine growth factors, overex-
pression of a PI 3-kinase or alteration of a regulatory
protein could also contribute. Fluorescence at the lateral as
well as the basal surface suggests that cell–cell contact, as
well as cell–matrix contact, is able to signal PI 3-kinase
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Figure 1
Use of a phosphospecific anti-Akt antibody to follow membrane
translocation of endogenous Akt/PKB in NIH3T3 cells. NIH3T3 cells
were grown on glass coverslips and (a) starved overnight
or (b,c) starved overnight and then stimulated with 50 ng/ml PDGF-BB
(Amersham) for 5 min. The cells were stained with an antibody raised
against a phosphopeptide flanking the Ser473 phosphorylation site of
Akt/PKB in the (a,b) absence or (c) presence of 100 ng/ml
phosphopeptide, as described in the Supplementary material. (d) In
parallel, lysates were generated from cells starved overnight (no
stimulus) or stimulated with PDGF for 5 min and the phosphorylation
state of Akt/PKB at Ser473 was assessed by western blotting. (e) The
specificity of the phosphospecific antibody was confirmed by probing
the western blots with the antibody in the presence of phosphopeptide.
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activation, although the absence of Akt/PKB from the
apical surface suggests that lipids produced by PI 3-kinase
do not freely diffuse throughout the plasma membrane.
The localisation of GFP–AH was examined in MDCK
cells shortly after they were plated on collagen in the
absence or presence of serum. The vertical and horizontal
confocal images (Figure 3e–j) show that GFP–AH localised
strongly to cell–cell contacts when cells were replated on
collagen in the presence of serum. It did not localise to
regions of the plasma membrane where the cell was not in
contact with another cell or with the matrix. In addition,
GFP–AH was found at discrete sites on the basal surface of
newly plated cells; this localisation occurred in either the
presence (Figure 3e–j) or absence (Figure 3k–m) of serum,
consistent with the fact that matrix induction of PI 
3-kinase activity is not dependent on serum factors [3].
The basal structures appeared rapidly on adhesion, and
then progressed over a few hours to the more even basal
membrane staining seen in long-term attached cells. The
localisation of GFP–AH to both the cell–cell contacts and
basal structures was dependent on its ability to bind 3′
phosphoinositides, as GFP–AHR25C remained distributed
throughout the cytoplasm (Figure 3n–p). To further
examine the sites where GFP–AH was found on the basal
surface of cells plated on collagen, cells were fixed shortly
after they were plated on collagen and analysed by confo-
cal immunofluorescence microscopy (Figure 3q–v).
GFP–AH co-localised with β-catenin but not with the focal
adhesion protein vinculin; the major localisation of
GFP–AH at sites of cell–matrix contact is therefore not
coincident with focal adhesions, so here p125FAK is
perhaps unlikely to have the major role in matrix-induced
PI 3-kinase activation that has been proposed [11]. 
These experiments suggest that survival-promoting PI 
3-kinase activity is induced in epithelial cells not just by
cell–matrix interactions but also by cell–cell interactions.
Some previous work has suggested that cell–cell interaction
promotes the survival of various types of epithelial cell,
including mouse intestinal epithelium [12], a human colon
carcinoma cell line [13], mouse primary mammary alveolar
cells [14] and human colonic adenoma cell lines [15]. The
mechanism for this protection has not been apparent,
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Translocation of GFP–AH and GFP–Akt to the plasma membrane in
fibroblasts. NIH3T3 cells were transiently transfected with
either (a–h) GFP–AH, (i–o) GFP–Akt, or (p–w) the indicated GFP
constructs. For (q,s) cells were cotransfected with the indicated GFP
construct and p110CAAX. The cells were serum starved for 8 h and
confocal images were taken of (a,i,p–s) unstimulated cells and
(b,j) cells stimulated with 30 ng/ml PDGF for 2 min, (c,k) 30 ng/ml
PDGF for 8 min, (l) 30 ng/ml PDGF for 30 min, (d,m) 30 ng/ml PDGF
for 8 min after a 1 h pretreatment with 30 µM C2-ceramide,
(e) 50 ng/ml EGF for 2 min, (f) 10 µg/ml insulin for 5 min, (g) 0.5% calf
serum for 5 min, (h) 0.5% serum for 5 min followed by a 10 min
incubation with 20 µM LY294002, (n,o) 30 ng/ml PDGF for 8 min after
a 10 min pretreatment with either (n) 20 µM LY294002 or (o) 100 nM
wortmannin. Cells expressing (t) the GFP vector and (u–w) mutant
versions of GFP–AH and GFP–Akt were also examined following an
8 min treatment with PDGF.
however. Experimentally it has been difficult to dissociate
signals due to epithelial cell–matrix interaction from signals
due to cell–cell interaction as these cells quickly form
cell–cell junctions in monolayer culture, even at low
density. We propose that PI 3-kinase is important not just
in survival signals induced by cell–matrix interactions but
also in those induced by cell–cell interactions. At present,
the mechanism for activation of PI 3-kinase at either of
these sites is not known, but it is noted that β-catenin
occurs at both locations and could therefore perhaps have a
role. Whether or not the ability of the Akt/PKB substrate
glycogen synthase kinase-3 to control the stability of 
β-catenin is relevant to the PI-3-kinase-mediated survival
pathway will be the subject of future investigations.
Supplementary material
Additional methodological detail and figures showing a schematic rep-
resentation of the GFP fusion proteins and their expression and kinase
activities are published with this paper on the internet.
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Figure 3
Cellular localisation of GFP–AH in MDCK epithelial cells.
(a) Horizontal (upper part of panel) and vertical (lower part of panel)
confocal images were taken of polarised MDCK cells growing on
permeable filters in 10% serum and stably expressing GFP–AH. The
yellow line in the lower part of the panel shows where the horizontal
section shown in the upper part was taken. (b–d) MDCK cells
transiently expressing GFP–AH were (b,c) serum-starved overnight or
(d) starved overnight and then incubated with LY294002 for 10 min.
(e–m) MDCK cells transiently expressing GFP–AH were also
examined (e–g,k–m) 1 h or (h–j) 3 h after they were plated on type I
collagen in (e–j) the presence of or (k–m) the absence of 10%
serum. Confocal images were taken at the apical, lateral and basal
regions of the cells as indicated. (n–p) In parallel, confocal images
were taken of cells transiently expressing the mutant GFP–AHR25C.
(q–v) The localisation of GFP–AH at the basal region of MDCK cells
was further investigated by fixing the cells 1 h after they were plated
on collagen and processing them for immunostaining with either
(q–s) vinculin or (t–v) β-catenin antibodies. Merged images are
shown in (s,v). 
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